Biophore India Gets DCGI Nod To Manufacture COVID Drug Favipiravir
Hyderabad-based Biophore India Pharmaceuticals has received license from the Drug Controller General of India (DCGI) to manufacture Favipiravir. Favipiravir is used in the finished formulation to treat mild to moderate…
Share